Document:

Exhibit 10.1

Employment Agreement
This Employment Agreement (this “Agreement”), effective as of January 1, 2013 (the “Effective Date”), is made by and between Rotech Healthcare Inc., a Delaware corporation (together with any successor thereto, the “Company”), and Steven P. Alsene (the “Executive”) (collectively referred to herein as the “Parties”).  
RECITALS
WHEREAS, Executive and the Company have previously entered into that certain Amended and Restated Agreement with Respect to Rights Upon Termination of Employment, dated January 1, 2012 (the “Employment Letter”);
WHEREAS, Executive and the Company mutually desire that this Agreement replace and supersede in its entirety the Employment Letter; and
WHEREAS, Executive and the Company mutually desire that Executive provide services to the Company on the terms herein provided.  
AGREEMENT
NOW, THEREFORE, in consideration of the foregoing and of the respective covenants and agreements set forth below, the Parties hereto agree as follows:
1.Employment.
(a)    General.  The Company shall employ Executive and Executive shall remain in the employ of the Company, for the period and in the position set forth in this Section 1, and subject to the other terms and conditions herein provided. 
(b)    Employment Term.  The term of employment under this Agreement (the “Term”) shall be for the period beginning on the Effective Date, and ending on December 31, 2015, subject to earlier termination as provided in Section 3.  The Term shall automatically renew for additional twelve (12) month periods unless no later than twelve (12) months prior to the end of the applicable Term either party gives written notice of non-renewal (“Notice of Non-Renewal”) to the other, in which case Executive’s employment will terminate at the end of the then-applicable Term, subject to earlier termination as provided in Section 3. 
(c)    Position and Duties.  Executive shall serve as Chief Executive Officer of the Company with such responsibilities, duties and authority normally associated with such position and as may from time to time be assigned to Executive by the Board of Directors of Company (the “Board”).  Executive shall devote substantially all of Executive’s working time and efforts to the business and affairs of the Company (which shall include service to its affiliates) and shall not engage in outside business activities (including serving on outside boards or committees) without the consent of the Board, provided that Executive shall be permitted to (i) manage Executive’s personal, financial and legal affairs, (ii) participate in trade associations, and (iii) serve on the board of directors of not-for-profit or tax-exempt charitable organizations, in each case, subject to compliance with this Agreement and provided that such activities do not materially interfere with Executive’s performance of Executive’s duties and responsibilities hereunder.  Executive agrees to observe and comply with the rules and policies of the Company as 

 DC\2356411.6

adopted or amended by the Company from time to time, in each case, as set forth in writing and as delivered or made available to Executive (each, a “Policy”).  
2.    Compensation and Related Matters.
(a)    Annual Base Salary.  During the Term, Executive shall receive a base salary at a rate of $600,000 per annum, which shall be paid in accordance with the customary payroll practices of the Company and shall be pro-rated for partial years of employment.  Such annual base salary shall be reviewed (and may be adjusted) from time to time, but no less than annually, by the Board (such annual base salary, as it may be adjusted from time to time, the “Annual Base Salary”).
(b)    Bonus.  During the Term, Executive will be eligible to participate in an annual incentive program established by the Board.  Executive’s annual incentive compensation under such incentive program (the “Annual Bonus”) shall be targeted at 100% of Executive’s Annual Base Salary (the “Target Bonus”), with the actual amount of any Annual Bonus based on the achievement of performance goals as determined by the Board or the Compensation Committee of the Board.  Any such bonus shall be paid not later than March 15th of the calendar year immediately following the calendar year in which such bonus was earned.
(c)    Equity Award.  On the Effective Date, the Company will grant to Executive an option to purchase 400,000 shares of the Company’s common stock, subject to the terms and conditions of the of the Rotech Healthcare Inc. Common Stock Option Plan, as amended, and a stock option agreement in substantially the form of the Company’s standard stock option agreement.   
(d)    Benefits.  During the Term, Executive shall be eligible to participate in employee benefit plans, programs and arrangements of the Company (including medical, dental and 401(k) plans), consistent with the terms thereof and as such plans, programs and arrangements may be amended from time to time.  In no event shall Executive be eligible to participate in any severance plan or program of the Company, except as set forth in Section 4 of this Agreement. 
(e)    Vacation.  During the Term, Executive shall be entitled to paid personal leave in accordance with the Company’s Policies.  Any vacation shall be taken at the reasonable and mutual convenience of the Company and Executive. 
(f)    Business Expenses.  During the Term, the Company shall reimburse Executive for all reasonable travel and other business expenses incurred by Executive in the performance of Executive’s duties to the Company in accordance with the Company’s expense reimbursement Policy as in effect from time to time.  
(g)    Automobile Allowance.  During the Term, Executive will be entitled to either (a) an automobile allowance consistent with Company Policy or (b) the use of a Company owned or leased automobile with reimbursement by the Company for all normal and customary expenses associated with the operation of such automobile (e.g., insurance, gasoline and maintenance).
(h)    Transaction Bonus.  If the closing of a Change of Control (as defined below) occurs during the Term and on or prior to December 31, 2015, then subject to Executive’s continued employment with the Company on the date of the Change of Control, the Company shall pay to Executive a lump-sum cash payment concurrent with such closing in an amount equal to $1,800,000 (less applicable withholdings). 

2

 DC\2356411.6

(i)    Key Person Insurance.  At any time during the Term, the Company shall have the right to insure the life of Executive for the Company’s sole benefit.   The Company shall have the right to determine the amount of insurance and the type of policy.  Executive shall reasonably cooperate with the Company in obtaining such insurance by submitting to physical examinations, by supplying all information reasonably required by any insurance carrier, and by executing all necessary documents reasonably required by any insurance carrier, provided that any information provided to an insurance company or broker shall not be provided to the Company without the prior written authorization of Executive.  Executive shall incur no financial obligation by executing any required document, and shall have no interest in any such policy.  
3.    Termination.
Executive’s employment hereunder may be terminated by the Company or Executive, as applicable, without any breach of this Agreement under the following circumstances:
(a)    Circumstances.
(i)    Death.  Executive’s employment hereunder shall automatically terminate upon Executive’s death.  
(ii)    Disability.  If Executive has incurred a Disability, as defined below, the Company may terminate Executive’s employment.  
(iii)    Termination for Cause.  The Company may terminate Executive’s employment for Cause, as defined below.
(iv)    Termination without Cause.  The Company may terminate Executive’s employment without Cause, which shall include a termination of Executive pursuant to the Company’s electing not to renew the Term pursuant to Section 1(b).
(v)    Resignation from the Company for Good Reason.  Executive may resign Executive’s employment with the Company for Good Reason, as defined below.
(vi)    Resignation from the Company Without Good Reason.  Executive may resign Executive’s employment with the Company for any reason other than Good Reason or for no reason, which shall include a termination of Executive pursuant to Executive electing not to renew the Term pursuant to Section 1(b).  
(b)    Notice of Termination.  Any termination of Executive’s employment by the Company or by Executive under this Section 3 (other than termination pursuant to paragraph (a)(i)) shall be communicated by a written notice to the other party hereto (i) indicating the specific termination provision in this Agreement relied upon, (ii) setting forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of Executive’s employment under the provision so indicated, if applicable, and (iii) specifying a Date of Termination which, if submitted by Executive, shall be at least sixty (60) days following the date of such notice (a “Notice of Termination”); provided, however, that in the event Executive delivers a Notice of Termination to the Company, the Company may, in its sole discretion, change the Date of Termination to any date that occurs following the date of Company’s receipt of such Notice of Termination and is prior to the date specified in such Notice of Termination.  A Notice of Termination submitted by the Company may provide for a Date of Termination on the date Executive receives the Notice of Termination, or any date thereafter elected by the Company in its sole 

3

 DC\2356411.6

discretion.  The failure by the Company or Executive to set forth in the Notice of Termination any fact or circumstance which contributes to a showing of Cause or Good Reason shall not waive any right of such Party hereunder or preclude such Party from asserting such fact or circumstance in enforcing such Party’s rights hereunder.  
(c)    Company Obligations upon Termination.  Upon termination of Executive’s employment pursuant to any of the circumstances listed in Section 3, Executive (or Executive’s estate) shall be entitled to receive the sum of:  (i) the portion of Executive’s Annual Base Salary earned through the Date of Termination, but not yet paid to Executive; (ii) any vacation time that has been accrued but unused in accordance with Company’s Policies, (iii) any expenses owed to Executive pursuant to Section 2(f); and (iv) any amount accrued and arising from Executive’s participation in, or benefits accrued under, any of the Company’s employee benefit plans, programs or arrangements, which amounts shall be payable in accordance with the terms and conditions of such employee benefit plans, programs or arrangements (collectively, the “Company Arrangements”).  Except as otherwise expressly required by law (e.g., Consolidated Omnibus Budget Reconciliation Act of 1985 (“COBRA”)) or as specifically provided herein, all of Executive’s rights to salary, severance, benefits, bonuses and other compensatory amounts hereunder (if any) shall cease upon the termination of Executive’s employment hereunder.  In the event that Executive’s employment is terminated by the Company for any reason, Executive’s sole and exclusive remedy shall be to receive the payments and benefits described in this Section 3(c) or Section 4, as applicable.
(d)    Deemed Resignation.  Upon termination of Executive’s employment for any reason, Executive shall be deemed to have resigned from all offices and directorships, if any, then held with the Company or any of its affiliates.
4.    Severance Payments.
(a)    Termination for Cause or Termination Upon Death, Disability or Resignation from the Company Without Good Reason.  If Executive’s employment shall terminate as a result of Executive’s death pursuant to Section 3(a)(i) or  Disability pursuant to Section 3(a)(ii), pursuant to Section 3(a)(iii) for Cause, or pursuant to Section 3(a)(vi) for Executive’s resignation from the Company without Good Reason, then Executive shall not be entitled to any severance payments or benefits, except as provided in Section 3(c). 
(b)    Termination without Cause, or Resignation from the Company for Good Reason.  If Executive’s employment terminates without Cause pursuant to Section 3(a)(iv), or pursuant to Section 3(a)(v) for Good Reason, then, subject to Executive signing on or after Executive’s Separation from Service (as defined below) and before the 52nd day following Executive’s Separation from Service, and not revoking, a release of claims substantially in the form attached as Exhibit A to this Agreement, and Executive’s continued compliance with Sections 5 and 6, Executive shall receive, in addition to payments and benefits set forth in Section 3(c), the following:
(i)    a lump-sum cash payment, payable on the 60th day following the date of Executive’s Separation from Service, in an amount (less applicable withholdings) equal to: 
(A)    if such termination of employment occurs on or prior to December 31, 2014, the sum of (y) 150% of the Annual Base Salary (measured as of the time of the termination of employment and without mitigation due to any remuneration or other compensation earned by Executive following such 

4

 DC\2356411.6

termination of employment), and (z) 150% of the Target Bonus for the Company’s fiscal year in which the termination of employment occurs, or 
(B)    if such termination of employment occurs following December 31, 2014, the sum of (y) 200% of the Annual Base Salary (measured as of the time of the termination of employment and without mitigation due to any remuneration or other compensation earned by Executive following such termination of employment), and (z) 200% of the Target Bonus for the Company’s fiscal year in which the termination of employment occurs; and
(ii)    to the extent unpaid as of the Date of Termination, an amount of cash equal to any Annual Bonus earned by Executive for the Company’s fiscal year prior to the fiscal year in which the Date of Termination occurs, as determined by the Board in its discretion based upon actual performance achieved, which Annual Bonus, if any, shall be paid to Executive in the fiscal year in which the Date of Termination occurs on the later of the date when bonuses for such prior fiscal year are paid in the ordinary course to actively employed senior executives of the Company or the 60th day following Executive’s Separation from Service; and
(iii)    if Executive (and, if applicable, Executive’s covered dependents) timely elects continuation of health coverage under the Company’s benefit plans following the termination of employment in accordance with COBRA, the Company will pay the monthly premiums for such COBRA coverage for a period commencing on the date of Executive’s Separation from Service and ending on the first to occur of (1) the date that is 18 months following Executive’s Separation from Service, (2) the date that Executive and/or Executive’s covered dependents become no longer eligible for COBRA and (3) the date Executive becomes eligible to receive healthcare coverage from a subsequent employer; provided, that in the event the Company determines it cannot provide such payments without potentially violating applicable law or creating adverse tax consequences for the Company or Executive, the Company shall in lieu thereof provide Executive with a taxable monthly payment in an amount equal to 100% of the monthly premium that Executive would be required to pay to continue Executive’s and Executive’s covered dependents’ health coverage under the Company’s benefit plans in effect on the date of Executive’s Separation from Service under COBRA (based on the premium for the first month of COBRA continuation coverage), which monthly payment shall be made regardless of whether Executive elects COBRA continuation coverage and shall commence in the month following the month in which Executive’s Separation from Service occurs and shall end on the first to occur of (X) the date that is 18 months following Executive’s Separation from Service, (Y) the date that Executive and/or Executive’s covered dependents become no longer eligible for COBRA and (Z) the date Executive becomes eligible to receive healthcare coverage from a subsequent employer; and
(iv)    In the event the termination of Executive’s employment occurs on or within 12 months following the closing of a Change of Control that occurs after December 31, 2015, a lump-sum cash payment, payable on the 60th day following the date of Executive’s Separation from Service, in an amount equal to the sum of (1) 200% of the Annual Base Salary (measured as of the time of the termination of your employment and without mitigation due to any remuneration or other compensation earned by you following such termination of employment), and (2) 200% of the Target Bonus for the Company’s fiscal year in which the termination of employment occurs.    

5

 DC\2356411.6

(c)    Survival.  Notwithstanding anything to the contrary in this Agreement, the provisions of Sections 5 through 9 and Section 11 will survive the termination of Executive’s employment and the expiration or termination of the Term.
5.    Competition. Executive acknowledges that Executive has been provided with Confidential Information (as defined below) and, during the Term, the Company from time to time will provide Executive with access to Confidential Information. Ancillary to the rights provided to Executive as set forth in this Agreement and the Company’s provision of Confidential Information, and Executive’s agreements regarding the use of same, in order to protect the value of any Confidential Information, the Company and Executive agree to the following provisions against unfair competition, which Executive acknowledges represent a fair balance of the Company’s rights to protect its business and Executive’s right to pursue employment:
(a)    Executive shall not, at any time during the Restriction Period (as defined below), directly or indirectly engage in, have any equity interest in, manage or provide services to or operate any person, firm, corporation, partnership or business (whether as director, officer, employee, agent, representative, partner, security holder, consultant or otherwise) that engages in any business which competes with any portion of the Business (as defined below) of the Company anywhere that the Company operates as of the Date of Termination.  Nothing herein shall prohibit Executive from being a passive owner of not more than 2% of the outstanding equity interest in any entity that is publicly traded, so long as Executive has no active participation in the business of such entity.  
(b)    Executive shall not, at any time during the Restriction Period, directly or indirectly, (i) solicit, divert or take away any customers or clients (including any individual or entity who was a customer or client at any time during the 12‐month period immediately preceding the Date of Termination), or business acquisition or other business opportunity of the Company, (ii) contact or solicit with respect to hiring any employee of the Company, (iii) induce or otherwise counsel, advise or encourage any employee of the Company to leave the employment of the Company, or (iv) induce any distributor, representative or agent of the Company (including any individual or entity who was a distributor, representative or agent at any time during the 12‐month period immediately preceding the Date of Termination) to terminate or modify its relationship with the Company.
(c)    In the event the terms of this Section 5 shall be determined by any court of competent jurisdiction to be unenforceable by reason of its extending for too great a period of time or over too great a geographical area or by reason of its being too extensive in any other respect, it will be interpreted to extend only over the maximum period of time for which it may be enforceable, over the maximum geographical area as to which it may be enforceable, or to the maximum extent in all other respects as to which it may be enforceable, all as determined by such court in such action.
(d)    As used in this Section 5, (i) the term “Company” shall include the Company and its direct and indirect parents and subsidiaries; (ii) the term “Business” shall mean the business of the Company and shall include the provision of home medical equipment and related products and services, as such business may be expanded or altered by the Company during the Term; and (iii) the term “Restriction Period” shall mean the period beginning on the Effective Date and ending on the date 18 months following the Date of Termination.
(e)    Executive represents that Executive’s employment by the Company does not and will not breach any agreement with any former employer, including any non-compete agreement or any agreement to keep in confidence or refrain from using information acquired by Executive prior to Executive’s 

6

 DC\2356411.6

employment by the Company.  During Executive’s employment by the Company, Executive agrees that Executive will not violate any non-solicitation agreements that Executive entered into with any former employer or improperly make use of, or disclose, any information or trade secrets of any former employer or other third party, nor will Executive bring onto the premises of the Company or its affiliates or use any unpublished documents or any property belonging to any former employer or other third party, in violation of any lawful agreements with that former employer or third party.
(f)    Each Party (which, in the case of the Company, shall mean its officers and the members of the Board) agrees, during the Term and following the Date of Termination, to refrain from Disparaging (as defined below) the other Party and its affiliates, including, in the case of the Company, any of its services, technologies or practices, or any of its directors, officers, agents, representatives or stockholders, either orally or in writing.  Nothing in this paragraph shall preclude any Party from making truthful statements that are reasonably necessary to comply with applicable law, regulation or legal process, or to defend or enforce a Party’s rights under this Agreement.  For purposes of this Agreement, “Disparaging” means making remarks, comments or statements, whether written or oral, that impugn the character, integrity, reputation or abilities of the Person being disparaged.
6.    Nondisclosure of Proprietary Information.
(a)    Except in connection with the faithful performance of Executive’s duties hereunder or pursuant to Section 6(c) and (e), Executive shall, in perpetuity, maintain in confidence and shall not directly, indirectly or otherwise, use, disseminate, disclose or publish, or use for Executive’s benefit or the benefit of any person, firm, corporation or other entity (other than the Company) any confidential or proprietary information or trade secrets of or relating to the Company (including, without limitation, business plans, business strategies and methods, acquisition targets, intellectual property in the form of patents, trademarks and copyrights and applications therefor, ideas, inventions, works, discoveries, improvements, information, documents, formulae, practices, processes, methods, developments, source code, modifications, technology, techniques, data, programs, other know-how or materials, owned, developed or possessed by the Company, whether in tangible or intangible form, information with respect to the Company’s operations, processes, products, inventions, business practices, finances, vendors, suppliers, customers, potential customers, marketing methods, costs, prices, contractual relationships, regulatory status, prospects and compensation paid to employees or other terms of employment or other information, data or knowledge that arises out of or relates to the business affairs of the Company) (collectively, the “Confidential Information”), or deliver to any person, firm, corporation or other entity any document, record, notebook, computer program or similar repository of or containing any such Confidential Information.  The Parties hereby stipulate and agree that, as between them, any item of Confidential Information is important, material and confidential and affects the successful conduct of the businesses of the Company (and any successor or assignee of the Company).    
(b)    Upon termination of Executive’s employment with the Company for any reason, Executive will promptly deliver to the Company all correspondence, drawings, manuals, letters, notes, notebooks, reports, programs, plans, proposals, financial documents, or any other documents or property concerning the Company’s customers, business plans, marketing strategies, products, property or processes. 
(c)    Executive may respond to a lawful and valid subpoena or other legal process but shall give the Company the earliest possible notice thereof, shall, as much in advance of the return date as possible, make available to the Company and its counsel the documents and other information sought and 

7

 DC\2356411.6

shall assist such counsel at Company’s expense in resisting or otherwise responding to such process, in each case to the extent permitted by applicable laws or rules.
(d)    As used in this Section 6 and Section 7, the term “Company” shall include the Company and its direct and indirect parents and subsidiaries.  
(e)    Nothing in this Agreement shall prohibit Executive from (i) disclosing information and documents when required by law, subpoena or court order (subject to the requirements of Section 6(c) above), (ii) disclosing information and documents to Executive’s attorney, financial or tax adviser for the purpose of securing legal, financial or tax advice, (iii) disclosing Executive’s post-employment restrictions in this Agreement in confidence to any potential new employer, or (iv) retaining, at any time, Executive’s personal correspondence, Executive’s personal contacts and documents related to Executive’s own personal benefits, entitlements and obligations, including in electronic format.  In addition, following a termination of Executive’s employment for any reason other than Cause, Executive shall be entitled to retain Executive’s Company iPad, cellular phone and other similar communications equipment, provided that the Company may remove from such devices any Company Confidential Information. 
7.    Inventions.  
All rights to discoveries, inventions, improvements and innovations (including all data and records pertaining thereto) related to the business of the Company, whether or not patentable, copyrightable, registrable as a trademark, or reduced to writing, that Executive may discover, invent or originate during the Term or the term of Executive’s employment with the Company prior to the Effective Date, either alone or with others and whether or not during working hours or by the use of the facilities of the Company (“Inventions”), shall be the exclusive property of the Company.  Executive shall promptly disclose all Inventions to the Company, shall execute at the request of the Company any assignments or other documents the Company may deem reasonably necessary to protect or perfect its rights therein, and shall assist the Company, upon reasonable request and at the Company’s expense, in obtaining, defending and enforcing the Company’s rights therein. Executive hereby appoints the Company as Executive’s attorney-in‐fact to execute on Executive’s behalf any assignments or other documents reasonably deemed necessary by the Company to protect or perfect its rights to any Inventions.  
8.    Injunctive Relief.
It is recognized and acknowledged by Executive that a breach of the covenants contained in Sections 5, 6 and 7 will cause irreparable damage to Company and its goodwill, the exact amount of which will be difficult or impossible to ascertain, and that the remedies at law for any such breach will be inadequate.  Accordingly, Executive agrees that in the event of a breach of any of the covenants contained in Sections 5, 6 and 7, in addition to any other remedy which may be available at law or in equity, the Company will be entitled to specific performance and injunctive relief without the requirement to post bond.
9.    Assignment and Successors.
The Company may assign its rights and obligations under this Agreement to any of its affiliates or to any successor to all or substantially all of the business or the assets of the Company (by merger or otherwise), and may assign or encumber this Agreement and its rights hereunder as security for indebtedness of the Company and its affiliates.  This Agreement shall be binding upon and inure to the benefit of the Company, Executive and their respective successors, assigns, personnel and legal representatives, executors, administrators, heirs, distributees, devisees, and legatees, as applicable.  None 

8

 DC\2356411.6

of Executive’s rights or obligations may be assigned or transferred by Executive, other than Executive’s rights to payments hereunder, which may be transferred only by will or operation of law.  Notwithstanding the foregoing, Executive shall be entitled, to the extent permitted under applicable law and applicable Company Arrangements, to select and change a beneficiary or beneficiaries to receive compensation hereunder following Executive’s death by giving written notice thereof to the Company.  
10.    Certain Definitions.
(a)    50% Beneficial Owner.  “50% Beneficial Owner” shall mean a Person who is the “beneficial owner” (as defined under Paragraph 13(d) of the Exchange Act), directly or indirectly, of securities of the Company representing more than 50% of the combined voting power of the Company’s then-outstanding voting securities; provided, however, that the term “50% Beneficial Owner” shall not include any person who was a beneficial owner of outstanding voting securities of the Company on the Effective Date (an “Existing Shareholder”), including any group that may be formed which is comprised solely of Existing Shareholders or any affiliate of an Existing Shareholder to whom voting securities may be transferred if and for so long as the Existing Shareholder remains an indirect beneficial owner of the voting securities following such transfer, unless and until such time after the Effective Date as any such Existing Shareholder shall have acquired beneficial ownership (other than by means of a stock dividend, stock split, gift, inheritance or receipt of securities in compensation for individual services as a director or officer of the Company) of any additional voting securities of the Company.
(b)    Cause.  “Cause” shall include, without limitation, the termination of Executive’s  employment with the Company due to the occurrence of one or more of the following events as determined by a majority vote of the Board: 
(i)    Executive’s conviction or entry of a plea of guilty or nolo contendere to any felony, 
(ii)    Executive’s engagement in conduct constituting breach of fiduciary duty, willful misconduct or gross negligence relating to the Company or the performance of Executive’s duties (including intentional acts of employment discrimination or sexual harassment) or fraud which have a significant adverse effect on the Company, 
(iii)    Executive’s willful failure to follow a reasonable and lawful written directive of the Board (which shall be capable of being performed by Executive with reasonable effort), 
(iv)    Executive’s deliberate and continued failure to perform Executive’s material duties, and 
(v)    Executive’s intentional disparagement of the Company or any of its affiliate, subsidiary or parent companies or any of their collective executives, shareholders, directors, or officers in any written or oral communication.
Executive shall be entitled to receive 30 days’ prior written notice that the Board intends to meet to consider Executive’s termination for Cause and specifying the actions allegedly constituting Cause.
(c)    Change of Control.  “Change of Control” shall mean the first occurrence, after the Effective Date, of any of the following: (i) any Person other than the Company, any trustee or other fiduciary holding securities under an employee benefit plan of the Company or any affiliate of the Company, or any company owned, directly or indirectly, by the shareholders of the Company in 

9

 DC\2356411.6

substantially the same proportions as their ownership of stock of the Company, acquires beneficial ownership (as defined under Paragraph 13(d) of the Exchange Act) of voting securities of the Company and immediately thereafter is a 50% Beneficial Owner; (ii) during any period of 12 consecutive months commencing on or after the Effective Date, individuals who at the beginning of such period constitute the Board, and any new director (other than a director designated by a Person who has entered into an agreement with the Company to effect a transaction described in subparagraphs (i), (iii) or (iv) of this definition) whose election by the Board or nomination for election by the Company’s shareholders was approved by a vote of at least a majority of the directors then still in office who either were directors at the beginning of the period or whose election or nomination for election was previously so approved (the “Continuing Directors”), cease for any reason to constitute at least a majority thereof; (iii) the consummation of a merger, consolidation, recapitalization, or reorganization of the Company, or a reverse stock split of any class of voting securities of the Company, other than any such transaction which would result in at least 50% of the combined voting power of the voting securities of the Company or the surviving entity outstanding immediately after such transaction being beneficially owned by persons who together beneficially owned at least 80% of the combined voting power of the voting securities of the Company outstanding immediately prior to such transaction with the relative voting power of each such continuing holder compared to the voting power of each other continuing holder not substantially altered as a result of the transaction; provided that, for this purpose, such continuity of ownership (and preservation of relative voting power) shall be deemed to be satisfied if the failure to meet such 50% threshold (or to substantially preserve such relative voting power) is due solely to the acquisition of voting securities by an employee benefit plan of the Company or any affiliate of the Company, such surviving entity or a subsidiary thereof; or (iv) the sale or disposition by the Company of all or substantially all of the Company’s assets (or, to the extent permitted by Section 409A (as defined below) any transaction having a similar effect).  The foregoing notwithstanding, a transaction shall not constitute a Change of Control if its sole purpose is to change the state of the Company’s incorporation.  
(d)    Date of Termination.  “Date of Termination” shall mean (i) if Executive’s employment is terminated by Executive’s death, the date of Executive’s death; (ii) if Executive’s employment is terminated pursuant to Section 3(a)(ii) – (vi) either the date indicated in the Notice of Termination or the date specified by the Company pursuant to Section 3(b), whichever is earlier.
(e)    Disability.  “Disability” shall mean, at any time the Company or any of its affiliates sponsors a long-term disability plan for the Company’s employees,  “disability” as defined in such long-term disability plan for the purpose of determining a participant’s eligibility for benefits, provided, however, if the long-term disability plan contains multiple definitions of disability, “Disability” shall refer to that definition of disability which, if Executive qualified for such disability benefits, would provide coverage for the longest period of time. The determination of whether Executive has a Disability shall be made by the person or persons required to make disability determinations under the long-term disability plan.  At any time the Company does not sponsor a long-term disability plan for its employees, Disability shall mean Executive’s inability to perform, with or without reasonable accommodation, the essential functions of Executive’s position hereunder for a total of three months during any six-month period as a result of incapacity due to mental or physical illness as determined by a physician selected by the Company or its insurers and acceptable to Executive or Executive’s legal representative, with such agreement as to acceptability not to be unreasonably withheld or delayed.  Any refusal by Executive to submit to a medical examination for the purpose of determining Disability shall be deemed to constitute conclusive evidence of Executive’s Disability. 
(f)    Exchange Act.  “Exchange Act” shall mean the Securities Exchange Act of 1934, as amended.

10

 DC\2356411.6

(g)    Good Reason.  “Good Reason” shall mean the occurrence of any of the following events, unless Executive consents in writing to the applicable event: (i) a material decrease in Executive’s annual base salary, (ii) the Company requiring Executive to regularly report to work at a facility more than 50 miles from the primarily location of Executive’s employment as of the Effective Date, (iii) a material decrease in Executive’s authority, duties or responsibilities (other than in connection with a corporate transaction where Executive continues to hold the position referenced in Section 1(c) above with respect to the Company’s business, substantially as such business exists prior to the date of consummation of such corporate transaction, but does not hold such position with respect to the successor corporation), or (iv) a material breach of this Agreement by the Company.  Notwithstanding the foregoing, no Good Reason will have occurred unless and until Executive has:  (a) provided the Company, within 90 days of the occurrence of the facts and circumstances underlying the Good Reason event, written notice specifying that Executive is resigning from employment with the Company for Good Reason and the basis for Executive’s belief that Good Reason exists; and (b) provided the Company with an opportunity to cure the same within 30 days after the receipt of such notice.  If the Company shall not have cured or eliminated the event otherwise constituting Good Reason within 30 days after receipt of such notice, then upon expiration of the 30-day period, Executive’s employment hereunder shall automatically be terminated.
(h)    Person.  “Person” shall mean any individual, firm, corporation, partnership, limited liability company, incorporated or unincorporated association, joint venture, joint stock company, trust, governmental authority or other entity of any kind.
11.    Miscellaneous Provisions.
(a)    Governing Law.  This Agreement shall be governed, construed, interpreted and enforced in accordance with its express terms, and otherwise in accordance with the substantive laws of the State of Florida without reference to the principles of conflicts of law of the State of Florida or any other jurisdiction, and where applicable, the laws of the United States.
(b)    Validity.  The invalidity or unenforceability of any provision or provisions of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement, which shall remain in full force and effect.  
(c)    Notices.  Any notice, request, claim, demand, document and other communication hereunder to any Party shall be effective upon receipt (or refusal of receipt) and shall be in writing and delivered personally or sent by facsimile or certified or registered mail, postage prepaid, as follows:
		
	(i)
	If to the Company, the Chief Financial Officer or the General Counsel at its headquarters,

(ii)    If to Executive, at the last address that the Company has in its personnel records for Executive, or
(iii)    At any other address as any Party shall have specified by notice in writing to the other Party.
(d)    Counterparts.  This Agreement may be executed in several counterparts, each of which shall be deemed to be an original, but all of which together will constitute one and the same Agreement.  Signatures delivered by facsimile shall be deemed effective for all purposes.

11

 DC\2356411.6

(e)    Entire Agreement.  The terms of this Agreement are intended by the Parties to be the final expression of their agreement with respect to the subject matter hereof and from and after the Effective Date supersede all prior understandings and agreements, whether written or oral, including the entirety of the Employment Letter.  The Parties further intend that this Agreement shall constitute the complete and exclusive statement of their terms and that no extrinsic evidence whatsoever may be introduced in any judicial, administrative, or other legal proceeding to vary the terms of this Agreement.  
(f)    Amendments; Waivers.  This Agreement may not be modified, amended, or terminated except by an instrument in writing, signed by Executive and a duly authorized officer of Company (other than Executive).  By an instrument in writing similarly executed, Executive or a duly authorized officer of the Company (other than Executive) may waive compliance by the other Party with any specifically identified provision of this Agreement that such other Party was or is obligated to comply with or perform; provided, however, that such waiver shall not operate as a waiver of, or estoppel with respect to, any other or subsequent failure.  No failure to exercise and no delay in exercising any right, remedy, or power hereunder shall preclude any other or further exercise of any other right, remedy, or power provided herein or by law or in equity.  
(g)    No Inconsistent Actions.  The Parties hereto shall not voluntarily undertake or fail to undertake any action or course of action inconsistent with the provisions or essential intent of this Agreement.  Furthermore, it is the intent of the Parties hereto to act in a fair and reasonable manner with respect to the interpretation and application of the provisions of this Agreement.
(h)    Construction.  This Agreement shall be deemed drafted equally by both the Parties. Its language shall be construed as a whole and according to its fair meaning.  Any presumption or principle that the language is to be construed against any Party shall not apply.  The headings in this Agreement are only for convenience and are not intended to affect construction or interpretation.  Any references to paragraphs, subparagraphs, sections or subsections are to those parts of this Agreement, unless the context clearly indicates to the contrary.  Also, unless the context clearly indicates to the contrary, (a) the plural includes the singular and the singular includes the plural; (b) “and” and “or” are each used both conjunctively and disjunctively; (c) “any,” “all,” “each,” or “every” means “any and all,” and “each and every”; (d) “includes” and “including” are each “without limitation”; (e) “herein,” “hereof,” “hereunder” and other similar compounds of the word “here” refer to the entire Agreement and not to any particular paragraph, subparagraph, section or subsection; and (f) all pronouns and any variations thereof shall be deemed to refer to the masculine, feminine, neuter, singular or plural as the identity of the entities or persons referred to may require.
(i)    Arbitration.  Any controversy, claim or dispute arising out of or relating to this Agreement, shall be settled solely and exclusively by a binding arbitration process administered by American Arbitration Association (“AAA”) in Orlando, Florida.  Such arbitration shall be conducted in accordance with the then-existing AAA rules of practice and procedure, with the following exceptions if in conflict: (a) one arbitrator who is a retired judge shall be chosen by AAA; (b) each Party to the arbitration will pay one-half of the expenses and fees of the arbitrator, together with other expenses of the arbitration incurred or approved by the arbitrator; and (c) arbitration may proceed in the absence of any Party if written notice (pursuant to the AAA rules and regulations) of the proceedings has been given to such Party.  Each Party shall bear its own attorney’s fees and expenses; provided that the arbitrator may assess the prevailing Party’s fees and costs against the non-prevailing Party as part of the arbitrator’s award.  The Parties agree to abide by all decisions and awards rendered in such proceedings.  Such decisions and awards rendered by the arbitrator shall be final and conclusive.  All such controversies, claims or disputes shall be settled in this manner in lieu of any action at law or equity; provided, however, 

12

 DC\2356411.6

that nothing in this subsection shall be construed as precluding the bringing an action for injunctive relief or specific performance as provided in this Agreement.  This dispute resolution process and any arbitration hereunder shall be confidential and neither any Party nor the neutral arbitrator shall disclose the existence, contents or results of such process without the prior written consent of all Parties, except where necessary or compelled in a court to enforce this arbitration provision or an award from such arbitration or otherwise in a legal proceeding.  Notwithstanding the foregoing, Executive and the Company each have the right to resolve any issue or dispute over intellectual property rights by court action instead of arbitration.
(j)    Enforcement.  If any provision of this Agreement is held to be illegal, invalid or unenforceable under present or future laws effective during the term of this Agreement, such provision shall be fully severable; this Agreement shall be construed and enforced as if such illegal, invalid or unenforceable provision had never comprised a portion of this Agreement; and the remaining provisions of this Agreement shall remain in full force and effect and shall not be affected by the illegal, invalid or unenforceable provision or by its severance from this Agreement. Furthermore, in lieu of such illegal, invalid or unenforceable provision there shall be added automatically as part of this Agreement a provision as similar in terms to such illegal, invalid or unenforceable provision as may be possible and be legal, valid and enforceable.
(k)    Withholding.  The Company shall be entitled to withhold from any amounts payable under this Agreement any federal, state, local or foreign withholding or other taxes or charges which the Company is required to withhold. The Company shall be entitled to rely on an opinion of counsel if any questions as to the amount or requirement of withholding shall arise.
(l)    Section 409A.
(i)    General.  The intent of the Parties is that the payments and benefits under this Agreement comply with or be exempt from Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations and guidance promulgated thereunder (collectively, “Section 409A”) and, accordingly, to the maximum extent permitted, this Agreement shall be interpreted to be in compliance therewith.  
(ii)    Separation from Service.  Notwithstanding anything in this Agreement to the contrary, any compensation or benefits payable under this Agreement that is considered nonqualified deferred compensation under Section 409A and is designated under this Agreement as payable upon Executive’s termination of employment shall be payable only upon Executive’s “separation from service” with the Company within the meaning of Section 409A (a “Separation from Service”) and, except as provided below, any such compensation or benefits described in Section 4(b) shall not be paid, or, in the case of installments, shall not commence payment, until the 60th day following Executive’s Separation from Service (the “First Payment Date”).  Any installment payments that would have been made to Executive during the 60-day period immediately following Executive’s Separation from Service but for the preceding sentence shall be paid to Executive on the First Payment Date and the remaining payments shall be made as provided in this Agreement.
(iii)    Specified Employee.  Notwithstanding anything in this Agreement to the contrary, if Executive is deemed by the Company at the time of Executive’s Separation from Service to be a “specified employee” for purposes of Section 409A, to the extent delayed commencement of any portion of the benefits to which Executive is entitled under this Agreement is required in 

13

 DC\2356411.6

order to avoid a prohibited distribution under Section 409A, such portion of Executive’s benefits shall not be provided to Executive prior to the earlier of (i) the expiration of the six-month period measured from the date of Executive’s Separation from Service with the Company or (ii) the date of Executive’s death.  Upon the first business day following the expiration of the applicable Section 409A period, all payments deferred pursuant to the preceding sentence shall be paid in a lump sum to Executive (or Executive’s estate or beneficiaries), and any remaining payments due to Executive under this Agreement shall be paid as otherwise provided herein.  
(iv)    Expense Reimbursements.  To the extent that any reimbursements under this Agreement are subject to Section 409A, any such reimbursements payable to Executive shall be paid to Executive no later than December 31 of the year following the year in which the expense was incurred; provided, that Executive submits Executive’s reimbursement request promptly following the date the expense is incurred, the amount of expenses reimbursed in one year shall not affect the amount eligible for reimbursement in any subsequent year, other than medical expenses referred to in Section 105(b) of the Code, and Executive’s right to reimbursement under this Agreement will not be subject to liquidation or exchange for another benefit.
(v)    Installments.  Executive’s right to receive any installment payments under this Agreement shall be treated as a right to receive a series of separate payments and, accordingly, each such installment payment shall at all times be considered a separate and distinct payment as permitted under Section 409A.  Except as otherwise permitted under Section 409A, no payment hereunder shall be accelerated or deferred unless such acceleration or deferral would not result in additional tax or interest pursuant to Section 409A.
12.    Executive Acknowledgment.
Executive acknowledges that Executive has read and understands this Agreement, is fully aware of its legal effect, has not acted in reliance upon any representations or promises made by the Company other than those contained in writing herein, and has entered into this Agreement freely based on Executive’s own judgment.
[Signature Page Follows]

14

 DC\2356411.6

IN WITNESS WHEREOF, the Parties have executed this Agreement on the date and year first above written.
ROTECH HEALTHCARE INC.
By:    /s/ Philip L. Carter
Name:    Philip L. Carter
Title:    President & Chief Executive Officer

  
EXECUTIVE
By:      /s/ Steven P. Alsene
Steven P. Alsene

[Signature Page to Employment Agreement]
 DC\2356411.6

EXHIBIT A
Separation Agreement and Release
This Separation Agreement and Release (“Agreement”) is made by and between Steven P. Alsene (“Executive”) and Rotech Healthcare Inc., a Delaware corporation (the “Company”) (collectively, referred to as the “Parties” or individually referred to as a “Party”).  Capitalized terms used but not defined in this Agreement shall have the meanings set forth in the Employment Agreement (as defined below).
WHEREAS, the Parties have previously entered into that certain Employment Agreement, effective as of January 1, 2013 (the “Employment Agreement”); and 
WHEREAS, in connection with Executive’s termination of employment with the Company or a subsidiary or affiliate of the Company effective ________, 20__, the Parties wish to resolve any and all disputes, claims, complaints, grievances, charges, actions, petitions, and demands that Executive may have against the Company and any of the Releasees (as defined below), including, but not limited to, any and all claims arising out of or in any way related to Executive’s employment with or separation from the Company or its subsidiaries or affiliates but, for the avoidance of doubt, nothing herein will be deemed to release any rights or remedies in connection with Executive’s ownership of vested equity securities of the Company or one of its affiliates or Executive’s right to indemnification by the Company or any of its affiliates pursuant to contract or applicable law (collectively, the “Retained Claims”).
NOW, THEREFORE, in consideration of the severance payments and benefits described in Section 4(b) of the Employment Agreement, which, pursuant to the Employment Agreement, are conditioned on Executive’s execution and non-revocation of this Agreement, and in consideration of the mutual promises made herein, the Company and Executive hereby agree as follows:
1.    Severance Payments; Salary and Benefits.  The Company agrees to provide Executive with the severance payments and benefits described in Section 4(b) of the Employment Agreement, payable at the times set forth in, and subject to the terms and conditions of, the Employment Agreement. In addition, to the extent not already paid, and subject to the terms and conditions of the Employment Agreement, the Company shall pay or provide to Executive all other payments or benefits described in Section 3(c) of the Employment Agreement, subject to and in accordance with the terms thereof.
2.    Release of Claims.  Executive agrees that, other than with respect to the Retained Claims, the foregoing consideration represents settlement in full of all outstanding obligations owed to Executive by the Company, any of its direct or indirect subsidiaries and affiliates and any of their current and former officers, directors, equity holders, managers, employees, agents, investors, attorneys, shareholders, administrators, affiliates, benefit plans, plan administrators, insurers, trustees, divisions, and subsidiaries and predecessor and successor corporations and assigns (collectively, the “Releasees”).  Executive, on his own behalf and on behalf of any of Executive’s affiliated companies or entities and any of their respective heirs, family members, executors, agents, and assigns, other than with respect to the Retained Claims, hereby and forever releases the Releasees from, and agrees not to sue concerning, or in any manner to institute, prosecute, or pursue, any claim, complaint, charge, duty, obligation, or cause of action relating to any matters of any kind, whether presently known or unknown, suspected or unsuspected, that Executive may possess against any of the Releasees arising from any omissions, acts, facts, or damages that have occurred up until and including the Effective Date of this Agreement (as defined in Section 7 below), including, without limitation:

A-1

 DC\2356411.6

(a)    any and all claims relating to or arising from Executive’s employment  or service relationship with the Company or any of its direct or indirect subsidiaries or affiliates and the termination of that relationship;
(b)    any and all claims relating to, or arising from, Executive’s right to purchase, or actual purchase of any shares of stock or other equity interests of the Company or any of its affiliates, including, without limitation, any claims for fraud, misrepresentation, breach of fiduciary duty, breach of duty under applicable state corporate law, and securities fraud under any state or federal law;
(c)    any and all claims for wrongful discharge of employment; termination in violation of public policy; discrimination; harassment; retaliation; breach of contract, both express and implied; breach of covenant of good faith and fair dealing, both express and implied; promissory estoppel; negligent or intentional infliction of emotional distress; fraud; negligent or intentional misrepresentation; negligent or intentional interference with contract or prospective economic advantage; unfair business practices; defamation; libel; slander; negligence; personal injury; assault; battery; invasion of privacy; false imprisonment; conversion; and disability benefits;
(d)    any and all claims for violation of any federal, state, or municipal statute, including, but not limited to, Title VII of the Civil Rights Act of 1964; the Civil Rights Act of 1991; the Rehabilitation Act of 1973; the Americans with Disabilities Act of 1990; the Equal Pay Act; the Fair Credit Reporting Act; the Age Discrimination in Employment Act of 1967; the Older Workers Benefit Protection Act; the Employee Retirement Income Security Act of 1974; the Worker Adjustment and Retraining Notification Act; the Family and Medical Leave Act; and the Sarbanes-Oxley Act of 2002;
(e)    any and all claims for violation of the federal or any state constitution;
(f)     any and all claims arising out of any other laws and regulations relating to employment or employment discrimination;
(g)    any claim for any loss, cost, damage, or expense arising out of any dispute over the non-withholding or other tax treatment of any of the proceeds received by Executive as a result of this Agreement; and
(h)    any and all claims for attorneys’ fees and costs.
Executive agrees that the release set forth in this section shall be and remain in effect in all respects as a complete general release as to the matters released.  This release does not release claims that cannot be released as a matter of law, including, but not limited to, Executive’s right to file a charge with or participate in a charge by the Equal Employment Opportunity Commission, or any other local, state, or federal administrative body or government agency that is authorized to enforce or administer laws related to employment, against the Company (with the understanding that Executive’s release of claims herein bars Executive from recovering such monetary relief from the Company or any other Releasee), claims for unemployment compensation or any state disability insurance benefits pursuant to the terms of applicable state law, claims to continued participation in certain of the Company’s group benefit plans pursuant to the terms and conditions of COBRA, claims to any benefit entitlements vested as the date of separation of Executive’s employment, pursuant to written terms of any employee benefit plan of the Company or its affiliates and Executive’s right under applicable law and any Retained Claims.  This release further does not release claims for breach of Section 3(c) or Section 4(b) of the Employment Agreement.

A-2

 DC\2356411.6

3.    Acknowledgment of Waiver of Claims under ADEA.  Executive understands and acknowledges that Executive is waiving and releasing any rights Executive may have under the Age Discrimination in Employment Act of 1967 (“ADEA”), and that this waiver and release is knowing and voluntary.  Executive understands and agrees that this waiver and release does not apply to any rights or claims that may arise under the ADEA after the Effective Date of this Agreement.  Executive understands and acknowledges that the consideration given for this waiver and release is in addition to anything of value to which Executive was already entitled.  Executive further understands and acknowledges that Executive has been advised by this writing that:  (a) Executive should consult with an attorney prior to executing this Agreement; (b) Executive has 21 days within which to consider this Agreement; (c) Executive has 7 days following Executive’s execution of this Agreement to revoke this Agreement pursuant to written notice to the General Counsel of the Company; (d) this Agreement shall not be effective until after the revocation period has expired; and (e) nothing in this Agreement prevents or precludes Executive from challenging or seeking a determination in good faith of the validity of this waiver under the ADEA, nor does it impose any condition precedent, penalties, or costs for doing so, unless specifically authorized by federal law.  In the event Executive signs this Agreement and returns it to the Company in less than the 21 day period identified above, Executive hereby acknowledges that Executive has freely and voluntarily chosen to waive the time period allotted for considering this Agreement.
4.    Severability.  In the event that any provision or any portion of any provision hereof or any surviving agreement made a part hereof becomes or is declared by a court of competent jurisdiction or arbitrator to be illegal, unenforceable, or void, this Agreement shall continue in full force and effect without said provision or portion of provision.
5.    No Oral Modification.  This Agreement may only be amended in a writing signed by Executive and a duly authorized officer of the Company.
6.    Governing Law; Dispute Resolution.  This Agreement shall be subject to the provisions of Sections 11(a), 11(c) and 11(i) of the Employment Agreement.
7.    Effective Date.  If Executive has attained or is over the age of 40 as of the date of Executive’s termination of employment, then each Party has seven days after that Party signs this Agreement to revoke it and this Agreement will become effective on the eighth day after Executive signed this Agreement, so long as it has been signed by the Parties and has not been revoked by either Party before that date (the “Effective Date”).  If Executive has not attained the age of 40 as of the date of Executive’s termination of employment, then the “Effective Date” shall be the date on which Executive signs this Agreement.
8.    Voluntary Execution of Agreement.  Executive understands and agrees that Executive executed this Agreement voluntarily, without any duress or undue influence on the part or behalf of the Company or any third party, with the full intent of releasing all of Executive’s claims against the Company and any of the other Releasees.  Executive acknowledges that:  (a) Executive has read this Agreement; (b) Executive has not relied upon any representations or statements made by the Company that are not specifically set forth in this Agreement; (c) Executive has been represented in the preparation, negotiation, and execution of this Agreement by legal counsel of his own choice or has elected not to retain legal counsel; (d) Executive understands the terms and consequences of this Agreement and of the releases it contains; and (e) Executive is fully aware of the legal and binding effect of this Agreement.
[Signature Page Follows]

A-3

 DC\2356411.6

IN WITNESS WHEREOF, the Parties have executed this Agreement on the respective dates set forth below.  
	
			
	 
	 
	EXECUTIVE

	Dated: _________________
	 
	___________________________________

	 
	 
	Steven P. Alsene

	 
	 
	 

	 
	 
	ROTECH HEALTHCARE INC.

	Dated: _________________
	By: 
	___________________________________

	 
	 
	Name: 

	 
	 
	Title:

A-4

 DC\2356411.6Subscription Agreement

 Exhibit 10.1 
 EXECUTION VERSION 
 SUBSCRIPTION AGREEMENT 

THIS SUBSCRIPTION AGREEMENT (the “Agreement”) is dated as of December 7, 2012, by and between Pinedale GP, Inc., a
Delaware corporation (the “General Partner”), Ross Avenue Investments, LLC, a Delaware limited liability company (the “Limited Partner” and together with the General Partner, the “Investors”), and
Pinedale Corridor, LP, a Delaware limited partnership (the “Company”). 
 RECITALS 

A. On the date hereof, the Company is entering into a Purchase and Sale Agreement with Ultra Wyoming, Inc., for the acquisition of
certain assets, all as set forth therein (the “Purchase Agreement”). 
 B. The Investors desire to purchase
from the Company, and the Company desires to sell to: (i) the Limited Partner, Class B Limited Partnership Interest Units of the Company set forth next to the Limited Partner’s name in Schedule A attached hereto (the “Class
B Units”), and (ii) the General Partner, General Partnership Interest Units of the Company set forth next to the General Partner’s name in Schedule A attached hereto (the “GP Units” and together with the
Class B Units, the “Units”). 
 C. In connection with this investment, the Investors and the Company desire to
obtain certain representations, warranties and agreements from each other. 
 NOW THEREFORE, in consideration of the mutual
promises and covenants contained herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows: 

AGREEMENT 
  

	1.	Subscription and Closing. 

1.1 Subscription. Subject to the terms and conditions of this Agreement, each Investor hereby agrees to contribute that amount of
capital set forth opposite such Investor’s name on Schedule A attached hereto, in consideration for the Units set forth opposite such Investor’s name on Schedule A attached hereto (the aggregate consideration to be paid for
the Units shall be referred to as the “Capital Contributions”). 
 1.2 Subscription Closing. The
purchase and sale of the Units provided for in this Agreement (the “Subscription Closing”) will take place electronically by fax or email on or before the Closing Date (as defined in the Purchase Agreement) or such other date agreed
in writing by the parties hereto (such date, the “Subscription Closing Date”), subject to the satisfaction or waiver of all the conditions set forth in Section 1.3 and Section 1.4. 

1.3 Company Subscription Closing Conditions. The obligations of the Company to complete the issuance of the Units to the Investors
on the Subscription Closing Date pursuant hereto, are subject to the satisfaction of the following conditions: 

(a) the representations and warranties of the Investors set forth in Section 3 hereof shall be true and
correct in all material respects on the Subscription Closing Date as though made on and as of such date; 

 (b) the First Amended and Restated Limited Partnership Agreement, in the
form attached hereto as Schedule B (the “Partnership Agreement”), duly executed by each Investor, shall be delivered to the Company; and 
 (c) each Investor shall have contributed its portion of the Capital Contributions as set forth next to such Investor’s name on Schedule A attached hereto in accordance with the wiring or other
transfer instructions provided by the Company at least three (3) business days prior to the Subscription Closing Date. 

1.4 Investor Subscription Closing Conditions. The obligations of the Investors to contribute their portion of the Capital
Contributions, are subject to the satisfaction of each of the following conditions: 
 (a) the representations
and warranties of the Company set forth in Section 2 hereof shall be true and correct in all material respects on the Subscription Closing Date as though made on and as of such date; 

(b) the Partnership Agreement, duly executed by the Company, shall have been delivered to the Investors; 

(c) the Company shall deliver to each Investor a certificate representing its Units, with such certificate bearing the
legends required under the Partnership Agreement; and 
 (d) the Company shall deliver to the Investors a
certificate executed by the Company stating that all of the closing conditions set forth in Section 11.2 of the Purchase Agreement have been satisfied or fulfilled or will be satisfied contemporaneously with or promptly following the
Subscription Closing, including the receipt of other funds that, together with the Capital Contributions, will enable the Company to pay the Purchase Price (as defined in the Purchase Agreement). 

 

	2.	Representations and Warranties of the Investors. 

 Each Investor hereby represents and warrants to the Company, severally and not jointly, solely with respect to itself, that the representations and warranties contained in this Section 2 are
true and correct as of the date hereof and shall survive the Subscription Closing: 
 2.1 Corporate Existence. Such
Investor is duly organized, legally existing and in good standing under the laws of the state in which it is incorporated or organized. Such Investor is not in default in the performance, observance or fulfillment of any provision of its
incorporation or organizational documents. 
 2.2 Authority; Enforceability. Such Investor has all necessary power
and authority to execute, deliver and perform its obligations hereunder and under the Partnership Agreement. This Agreement constitutes the legal, valid and binding obligation of such Investor, enforceable in accordance with its terms, except as
such enforceability may be limited by bankruptcy, insolvency, fraudulent transfer and similar laws affecting creditors’ rights generally or by general principles of equity. 

  
 2 

 2.3 Financial Condition. (a) Such Investor’s financial condition is such
that it is able to bear the risk of holding the Units for an indefinite period of time, it has adequate means to provide for its current financial needs and contingencies, it has no need for immediate liquidity in this investment and is able to risk
the loss of its entire investment in the Units; (b) such Investor or its advisors have such knowledge and experience in financial and business matters that it is capable of evaluating the merits and risks of acquisition of the Units and of
making an informed investment decision with respect thereto; (c) such Investor has read, understood and is familiar with the information about the Company as provided to it, including the transactions contemplated by the Purchase Agreement, and
such Investor is not subscribing for the Units as a result of any advertisement, article, notice or other communication; (d) the Company has made available all additional information which was requested by such Investor in connection with the
transactions contemplated by this Agreement and the Purchase Agreement, as well as the opportunity to ask questions and receive answers from the Company concerning the terms and conditions of the purchase of the Units and the transactions
contemplated under the Purchase Agreement; (e) such Investor is purchasing the Units solely for its own account for the purpose of investment and not with a view to distribution or for sale in connection with any distribution thereof and has no
present intention or plan to affect any distribution of the Units and will not sell or otherwise transfer the Units without registration under the Securities Act of 1933, as amended (the “Securities Act”), or an exemption therefrom,
provided each Investor will be free to sell pursuant to the terms of the Partnership Agreement and other applicable LGS Transaction Documents (as defined in the Partnership Agreement); (f) such Investor’s overall commitment to investments
that are not readily marketable is not disproportionate to its net worth and its investment in the Units will not cause such overall commitments to become excessive; and (g) such Investor’s financial condition is such that it is under no
present or contemplated future need for its portion of the Capital Contributions or to dispose of any portion of the Units to satisfy any existing or contemplated undertaking, need or indebtedness. 

2.4 Units Not Registered. Such Investor understands that the Units have not been registered under the Securities Act or any state
securities laws in reliance on an exemption from registration for private offerings, and no federal or state agency has made any findings or determination as to the fairness of this investment or any recommendation or endorsement of the offering of
the Units. Such Investor further understands that it is subscribing to purchase the Units without relying on any offering literature other than the information described in Section 2.1 above. 

2.5 Additional Acknowledgments. Such Investor acknowledges and is aware of the following: 

(a) The Company has no operating history; 

(b) The Units constitute a speculative investment and involves a high degree of risk of loss by such Investor of its total
investment; and 
 (c) There are substantial restrictions on the transferability of the Units. The Units cannot
be transferred or sold unless registered under the Securities Act or an exemption from such registration is available from it and applicable state securities laws and established to the satisfaction of the Company; investors in the Company have no
rights to require that their 

  
 3 

 
respective Units be registered; there is no public market for the Units. Additionally, the Units are further subject to restrictions on transfer pursuant to the Partnership Agreement as set forth
therein. Accordingly, such Investor may have to hold the Units indefinitely and it may not be possible for such Investor to readily liquidate its investment in the Company. 
 2.6 Accredited Investor. Such Investor is an “accredited investor” as that term is defined in Rule 501 of Regulation D of the Securities Act. 

2.7 GP Representation. The General Partner represents and warrants to the Limited Partner and to the Company that as of the
closing of the LGS Transaction (as defined in the Partnership Agreement), all representations and warranties made by the General Partner in the LGS Transaction Documents, if any, will be true and correct and the General Partner will not be in breach
of any of its undertakings thereunder, if any. 
  

	3.	Representations and Warranties of the Company. 

 The Company hereby represents and warrants to the Investors that the representations and warranties contained in this Section 3 are true and correct as of the date hereof and shall survive the
Subscription Closing: 
 3.1 Corporate Existence. The Company is a limited partnership duly organized, legally existing
and in good standing under the laws of the State of Delaware. The Company is not in default in the performance, observance or fulfillment of any provision of its current partnership agreement or its Certificate of Limited Partnership. 

3.2 Capitalization and Valid Issuance of Units. Immediately following the Subscription Closing, each Investor’s Percentage
Interest (as defined in the Partnership Agreement), and the number and class of Units held by each Investor, and all outstanding Units, shall be as set forth in Exhibit A to the Partnership Agreement. Upon issuance, all Units will be duly
authorized and validly issued in accordance with the Partnership Agreement and fully paid and nonassessable, free and clear of any liens. 
 3.3 No Breach. The execution, delivery and performance by the Company of this Agreement, the compliance by the Company with the terms and provisions hereof, and the sale of the Units by the Company
do not and will not: (a) violate any provision of any law, statute, rule, regulation, order, writ, judgment, injunction, decree, governmental permit, determination or award having applicability to the Company, or (b) require any consent,
approval or notice under or result in a violation or breach of or constitute (with or without due notice or lapse of time or both) a default (or give rise to any right of termination, cancellation or acceleration) under any agreement, instrument or
obligation. 
 3.4 Authority; Enforceability. The Company has all necessary power and authority to execute, deliver and
perform its obligations hereunder. This Agreement constitutes the legal, valid and binding obligation of the Company, enforceable in accordance with its terms, except as such enforceability may be limited by bankruptcy, insolvency, fraudulent
transfer and similar laws affecting creditors’ rights generally or by general principles of equity. 
 3.5
Approvals. No authorization, consent, approval, waiver, license, qualification or written exemption from, nor any filing, declaration, qualification or registration with, any governmental authority or any other person is required in
connection with the execution, delivery or performance by the Company of this Agreement and the Partnership Agreement. 

  
 4 

 3.6 LGS Transaction Documents. As of the closing of the LGS Transaction, all
representations and warranties made by the Company in the LGS Transaction Documents will be true and correct and the Company will not be in breach of any of its undertakings thereunder. 

 

	4.	Termination. 

 (a) Notwithstanding anything herein to the contrary, this Agreement shall automatically terminate if the Subscription Closing shall not have occurred on or before the Outside Closing Date (as defined in
the Purchase Agreement) or any other termination of the Purchase Agreement, unless the term hereof is extended by agreement of the parties hereto. In the event the LGS Transaction is not consummated by the first business day following the
Subscription Closing, then the Subscription Closing shall be unwound and the Partnership shall return the Capital Contributions received from each Partner. 
 (b) In the event of the termination of this Agreement as provided in Section 4(a), this Agreement shall forthwith become null and void. In the event of such termination, there shall be no
liability on the part of any party hereto; provided that nothing herein shall relieve any party from any liability or obligation with respect to any willful breach of this Agreement. 

 

	5.	Miscellaneous. 

 5.1
Titles and Captions. All section titles or captions in this Agreement are for convenience only. They shall not be deemed part of this Agreement and do not in any way define, limit, extend or describe the scope or intent of any provisions
hereof. 
 5.2 Assignability. Except in connection with the valid transfer of Units in accordance with the Partnership
Agreement and applicable law, this Agreement is not transferable or assignable by the Investors. 
 5.3 Further Action.
The parties shall execute and deliver all documents, provide all information and take or forbear from taking all such action as may be necessary or appropriate to achieve the purposes of this Agreement. 

5.4 Applicable Law. The parties acknowledge and agree that any claim, controversy, dispute or action relating in any way to this
Agreement or the subject matter of this Agreement shall be governed solely by the laws of the State of Delaware, without regard to any conflict of laws doctrines. 
 5.5 Integration. This Agreement, together with the Partnership Agreement, constitutes the entire agreement among the parties pertaining to the subject matter hereof and supersedes and replaces all
prior and contemporaneous agreements and understandings, whether written or oral, pertaining thereto. No covenant, representation or condition not expressed in this Agreement or in the Partnership Agreement (or, if applicable, any supplemental
agreement to this Agreement) shall affect or be deemed to interpret, change or restrict the express provisions hereof. 

  
 5 

 5.6 Amendment. This Agreement may be modified or amended only with the written
approval of all parties hereto. 
 5.7 Waiver. No failure by any party to insist upon the strict performance of any
covenant, agreement, term or condition of this Agreement or to exercise any right or remedy available upon a breach thereof shall constitute a waiver of any such breach or of such or any other covenant, agreement, term or condition. 

5.8 Counterparts. This Agreement may be executed in counterparts, all of which taken together shall constitute one agreement
binding on all the parties notwithstanding that all the parties are not signatories to the original or the same counterpart. 

5.9 Public Announcements. No party shall issue any press release or other public statement with respect to the transactions
contemplated hereby, without the prior approval of the other parties (not to be unreasonably withheld), except as may be required by applicable law or exchange listing requirements. 

5.10 Third-Party Beneficiaries. The provisions of this Agreement are for the exclusive benefit of the parties hereto and their
successors and permitted assigns, with the sole exception that KeyBanc Capital Markets Inc. and Merrill Lynch, Pierce, Fenner & Smith Incorporated are hereby recognized by the parties as intended third-party beneficiaries of the
representations and warranties set forth in Sections 2 and 3. 
 [Remainder of Page Intentionally Left Blank] 

  
 6 

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of
the date first written above. 
  

			
	COMPANY:
	
	Pinedale Corridor, LP
		
	By:	 	Pinedale GP, Inc., its General Partner
		
		 	  

		 	Name: David J. Schulte
		 	Title: President
	
	INVESTORS:
	
	Pinedale GP, Inc.
	
	  

	Name: David J. Schulte
	Title: President
	
	Ross Avenue Investments, LLC
	
	  

	Name:	 	  

	Title:	 	  

 [Signature Page to Subscription Agreement] 

 SCHEDULE A 

 

							
	 Name and Address
	  	 Percentage

Interest
	  	 Units
	  	 Capital Contributions

	 General Partner

 
 Pinedale GP, Inc.

4200 W.
115th Street, Suite 210

Overland Park, KS 66211
	  	81.71%	  	 817.1
 General Partnership Interest Units
	  	$130,000,000, plus additional cash as necessary to cover all costs and expenses to be paid or reimbursed by the Partnership pursuant to Section 2.5 of the
Partnership Agreement (estimated $4,000,000)
				
	 Limited Partner

 
 Ross Avenue Investments LLC

c/o Prudential Capital Group
 2200 Ross Avenue
 Suite 4200E

Dallas TX 75201-2758

Attn: Managing Director, Energy
 Finance Group – Oil & Gas
	  	18.29%	  	 182.9
 Class B Limited Partnership Interest
 Units
	  	$30,000,000

 SCHEDULE B 
 First Amended and Restated Partnership Agreement

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00210-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00210-of-00352.parquet"}]]